Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Trial Comparing Rituximab Against Mycophenolate Mofetil in Children Wtih Refractory Nephrotic Syndrome (RAMP)

NCT02390362 is registered in ClinicalTrials.gov with Nationwide Children's Hospital as lead sponsor.

NCT NCT02390362
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02390362 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Trial Comparing Rituximab Against Mycophenolate Mofetil in Children Wtih Refractory Nephrotic Syndrome (RAMP)
Lead sponsor
Nationwide Children's Hospital
Phase
Phase 3
Overall status
Terminated
Start date
January 31, 2015
Completion date
January 18, 2017
Enrollment
3 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

frequent relapsing nephrotic syndrome, steroid dependent nephrotic syndrome